First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2013-07-12 11:02:27Open Document File Size: 215,05 KBShare Result on FacebookCompanyNorth East Cancer Drugs Approval Group / Palliative Care Clinical Group / The North East Treatment Advisory Group / /CountryUnited States / United Kingdom / /CurrencyGBP / /EventFDA Phase / /IndustryTermmorphine solution / treatment of breakthrough pain associated with cancer / oral morphine solution / license applications / /MedicalConditioncancer / excessive drowsiness / headache / hallucinations / nausea / intractable constipation / pain / fatigue / drowsiness / breakthrough pain / dizziness / constipation / /MedicalTreatmentpain management / /OrganizationCommittee on Human Medicinal Products / European Medicines Agency / Medicines and Healthcare Products Regulatory Agency / NHS / National Patient Safety Agency / /PersonWilliam Horsley Lead Pharmacist / /Positioncancer Author / /ProductActiq / fentanyl / Fentora / Abstral® / Effentora® / Instanyl® / /Technologydrug delivery / /SocialTag |